News

Featured News

  • 2022 |
  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • Press Release | June 21, 2022

    Carbon Biosciences Launches with $38 Million Series A Financing to Advance Novel Gene Therapy Platform and Pipeline

    Read More

    Press Release | June 13, 2022

    ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immunotherapeutic Pipeline

    Read More

    Press Release | May 15, 2022

    Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease

    Read More

    Press Release | April 20, 2022

    Dragonfly Therapeutics Announces Multi-Target Expansion of its Research Collaboration with AbbVie to Develop Novel Therapeutic Candidates for Immune-Mediated Diseases

    Read More

    Press Release | April 8, 2022

    ImCheck Provides Updated ICT01 and Pembrolizumab Combination Data from the Phase I/IIa EVICTION Trial at AACR Annual Meeting 2022

    Read More

    Press Release | April 8, 2022

    Pyxis Oncology Announces Preclinical Data on Anti-Siglec-15 BSI-060T (PYX-106) Presented by Biosion, Inc. at the 2022 American Association for Cancer Research (AACR) Annual Meeting

    Read More

    News | March 22, 2022

    Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations

    Read More

    Press Release | March 1, 2022

    Dragonfly Therapeutics Announces Achievement of Phase 1 Clinical Development Milestone for IL-12 Investigational Immunotherapy Program with Bristol Myers Squibb

    Read More

    Press Release | February 28, 2022

    Freenome Launches the Vallania Study for the Early Detection of Multiple Cancers

    Read More

    News | February 28, 2022

    Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Fibromyalgia

    Read More

    Press Release | February 24, 2022

    Pliant Therapeutics Announces Positive DSMB Safety Review and Commencement of Enrollment of Phase 2a Trial of PLN-74809 at 320 mg Dose in Idiopathic Pulmonary Fibrosis

    Read More

    Press Release | February 3, 2022

    Orchard Therapeutics Announces Historic Agreement Making Libmeldy Available by NHS England for MLD Patients

    Read More

    News | January 28, 2022

    Cyrus Biotechnology CEO Lucas Nivon featured in Fierce Biotech Webinar

    Read More

    News | January 25, 2022

    Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform

    Read More

    Press Release | January 19, 2022

    Orbus Therapeutics’ Phase 3 Eflornithine STELLAR Study Reaches Full Patient Enrollment

    Read More

    Press Release | January 6, 2022

    Zenas BioPharma Appoints Dr. John Orloff to Board of Directors

    Read More